Your browser doesn't support javascript.
loading
Analytical Performance of Next-Generation Sequencing and RT-PCR on Formalin-Fixed Paraffin-Embedded Tumor Tissues for PIK3CA Testing in HR+/HER2- Breast Cancer.
Venetis, Konstantinos; Pepe, Francesco; Munzone, Elisabetta; Sajjadi, Elham; Russo, Gianluca; Pisapia, Pasquale; Ivanova, Mariia; Bonizzi, Giuseppina; Vacirca, Davide; Rappa, Alessandra; Ranghiero, Alberto; Taormina, Sergio Vincenzo; Viale, Giuseppe; Troncone, Giancarlo; Barberis, Massimo; Guerini-Rocco, Elena; Malapelle, Umberto; Fusco, Nicola.
Affiliation
  • Venetis K; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Giuseppe Ripamonti 435, 20141 Milan, Italy.
  • Pepe F; Department of Oncology and Hemato-Oncology, University of Milan, Via Festa del Perdono 7, 20122 Milan, Italy.
  • Munzone E; Department of Public Health, Federico II University of Naples, Via S. Pansini, 5, 80131 Naples, Italy.
  • Sajjadi E; Division of Medical Senology, IEO, European Institute of Oncology IRCCS, Via Giuseppe Ripamonti 435, 20141 Milan, Italy.
  • Russo G; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Giuseppe Ripamonti 435, 20141 Milan, Italy.
  • Pisapia P; Department of Oncology and Hemato-Oncology, University of Milan, Via Festa del Perdono 7, 20122 Milan, Italy.
  • Ivanova M; Department of Public Health, Federico II University of Naples, Via S. Pansini, 5, 80131 Naples, Italy.
  • Bonizzi G; Department of Public Health, Federico II University of Naples, Via S. Pansini, 5, 80131 Naples, Italy.
  • Vacirca D; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Giuseppe Ripamonti 435, 20141 Milan, Italy.
  • Rappa A; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Giuseppe Ripamonti 435, 20141 Milan, Italy.
  • Ranghiero A; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Giuseppe Ripamonti 435, 20141 Milan, Italy.
  • Taormina SV; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Giuseppe Ripamonti 435, 20141 Milan, Italy.
  • Viale G; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Giuseppe Ripamonti 435, 20141 Milan, Italy.
  • Troncone G; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Giuseppe Ripamonti 435, 20141 Milan, Italy.
  • Barberis M; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Giuseppe Ripamonti 435, 20141 Milan, Italy.
  • Guerini-Rocco E; Department of Oncology and Hemato-Oncology, University of Milan, Via Festa del Perdono 7, 20122 Milan, Italy.
  • Malapelle U; Department of Public Health, Federico II University of Naples, Via S. Pansini, 5, 80131 Naples, Italy.
  • Fusco N; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Giuseppe Ripamonti 435, 20141 Milan, Italy.
Cells ; 11(22)2022 11 09.
Article in En | MEDLINE | ID: mdl-36428975

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Limits: Female / Humans Language: En Journal: Cells Year: 2022 Document type: Article Affiliation country: Italia Country of publication: Suiza

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Limits: Female / Humans Language: En Journal: Cells Year: 2022 Document type: Article Affiliation country: Italia Country of publication: Suiza